PRNP and Creutzfeldt Jacob disease: Thus, it is predicted that AP fibril formation might suppress PrP evolvability (Figure 2(a)), and this view is in agreement with the observation that the accumulation of AP, such as amyloid deposits, in CJD patients is accompanied by a longer disease course [21], which may be a clue towards a therapeutic opportunity.